The Rationale for Utilizing an Optimized Formulary to Improve the Health and Economic Outcomes of Patients with Multiple Sclerosis

August 1, 2004

In the past 15 years, with the introduction of largemolecule, biologically engineered therapies, the treatment of multiple sclerosis (MS) has been revolutionized. While still not curable, today MS is eminently treatable.